Literature DB >> 17157385

The importance of cytochrome P450 2B6 in the human metabolism of environmental chemicals.

Ernest Hodgson1, Randy L Rose.   

Abstract

Cytochrome P450 (CYP) 2B6 (CYP2B6) is a human CYP isoform found in variable amounts in the liver and other organs. It is known to be inducible and polymorphic and has a wide range of xenobiotic substrates. Studies of CYP2B6 to date have concentrated heavily on clinical drugs. In the present communication, however, we concentrate on its role in the metabolism of environmental xenobiotics. The term environment is used, in its broadest sense, to include natural ecosystems and agroecosystems as well as the industrial and indoor domestic environments. In essence, this excludes only clinical drugs and drugs of abuse. Many of these chemicals, including agrochemicals and industrial chemicals, can serve as substrates, inhibitors and/or inducers of CYP2B6, these activities being often modified by the existence of polymorphic variants. Metabolism-based interactions between environmental chemicals are discussed, as well as the emerging possibility of metabolic interactions between environmental chemicals and clinical drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17157385     DOI: 10.1016/j.pharmthera.2006.10.002

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  32 in total

1.  Bioactivation of chlorpyrifos by CYP2B6 variants.

Authors:  Alice L Crane; Kathrin Klein; James R Olson
Journal:  Xenobiotica       Date:  2012-07-10       Impact factor: 1.908

2.  Effect of CYP2B6*6 and CYP2C19*2 genotype on chlorpyrifos metabolism.

Authors:  Alice L Crane; Kathrin Klein; Ulrich M Zanger; James R Olson
Journal:  Toxicology       Date:  2012-01-18       Impact factor: 4.221

3.  Efavirenz primary and secondary metabolism in vitro and in vivo: identification of novel metabolic pathways and cytochrome P450 2A6 as the principal catalyst of efavirenz 7-hydroxylation.

Authors:  Evan T Ogburn; David R Jones; Andrea R Masters; Cong Xu; Yingying Guo; Zeruesenay Desta
Journal:  Drug Metab Dispos       Date:  2010-03-24       Impact factor: 3.922

4.  Rifampin enhances cytochrome P450 (CYP) 2B6-mediated efavirenz 8-hydroxylation in healthy volunteers.

Authors:  Doo-Yeoun Cho; Joan H Q Shen; Suzanne M Lemler; Todd C Skaar; Lang Li; Julia Blievernicht; Ulrich M Zanger; Kwon-Bok Kim; Jae-Gook Shin; David A Flockhart; Zeruesenay Desta
Journal:  Drug Metab Pharmacokinet       Date:  2015-07-29       Impact factor: 3.614

5.  Allele and genotype frequencies of CYP2B6 in a Turkish population.

Authors:  Nazan Yuce-Artun; Gulcin Kose; H Sinan Suzen
Journal:  Mol Biol Rep       Date:  2014-02-22       Impact factor: 2.316

Review 6.  CYP/PON genetic variations as determinant of organophosphate pesticides toxicity.

Authors:  Gurpreet Kaur; A K Jain; Sandeep Singh
Journal:  J Genet       Date:  2017-03       Impact factor: 1.166

7.  Synergistically enhanced CYP2B6 inducibility between a polymorphic mutation in CYP2B6 promoter and pregnane X receptor activation.

Authors:  Haishan Li; Stephen S Ferguson; Hongbing Wang
Journal:  Mol Pharmacol       Date:  2010-07-12       Impact factor: 4.436

8.  CCAAT/enhancer-binding protein alpha (C/EBPalpha) and hepatocyte nuclear factor 4alpha (HNF4alpha) synergistically cooperate with constitutive androstane receptor to transactivate the human cytochrome P450 2B6 (CYP2B6) gene: application to the development of a metabolically competent human hepatic cell model.

Authors:  Marta Benet; Agustín Lahoz; Carla Guzmán; José V Castell; Ramiro Jover
Journal:  J Biol Chem       Date:  2010-07-09       Impact factor: 5.157

9.  Use of Phenoxyaniline Analogues To Generate Biochemical Insights into the Interactio n of Polybrominated Diphenyl Ether with CYP2B Enzymes.

Authors:  Chao Chen; Jingbao Liu; James R Halpert; P Ross Wilderman
Journal:  Biochemistry       Date:  2017-12-19       Impact factor: 3.162

10.  Rapid clinical induction of hepatic cytochrome P4502B6 activity by ritonavir.

Authors:  Evan D Kharasch; Darain Mitchell; Rebecka Coles; Roberto Blanco
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.